HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Robert Mikulik Selected Research

4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)

12/2015IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry.
9/2015Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.
8/2015Threshold for NIH stroke scale in predicting vessel occlusion and functional outcome after stroke thrombolysis.
6/2014Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register.
3/2014Role of preexisting disability in patients treated with intravenous thrombolysis for ischemic stroke.
7/2013Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
6/2012Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
6/2011Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke.
9/2010Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR.
9/2010Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Robert Mikulik Research Topics

Disease

24Stroke (Strokes)
12/2015 - 08/2006
4Cerebral Hemorrhage
12/2015 - 03/2009
2Hemorrhage
12/2015 - 06/2012
2Intracranial Hemorrhages (Intracranial Hemorrhage)
09/2015 - 06/2014
2Body Weight (Weight, Body)
06/2012 - 03/2010
1Transient Ischemic Attack
06/2014
1Atrial Fibrillation
06/2014
1Hypertension (High Blood Pressure)
06/2012
1Thrombosis (Thrombus)
02/2008

Drug/Important Bio-Agent (IBA)

15Tissue Plasminogen Activator (Alteplase)FDA Link
12/2015 - 08/2006
104- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
12/2015 - 09/2010
3glucuronyl glucosamine glycan sulfate (Vessel)IBA
08/2015 - 06/2011
2Blood Glucose (Blood Sugar)IBA
06/2014 - 09/2010
2ThrombinFDA Link
03/2012 - 08/2006
2argatroban (MPQA)FDA Link
03/2012 - 08/2006
1First StepIBA
09/2015
1Antihypertensive Agents (Antihypertensives)IBA
12/2012
1clopidogrel (Plavix)FDA Link
06/2012
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2012
1Glucose (Dextrose)FDA LinkGeneric
06/2012
1perflutren (octafluoropropane)FDA Link
05/2008

Therapy/Procedure

3Thrombolytic Therapy
06/2011 - 03/2009
1Aftercare (After-Treatment)
06/2014
1Microspheres (Microsphere)
05/2008